sixteen patients with advanced ( stage iii ) malignant melanoma were treated with escalating doses of intravenous bcnu and melphalan starting at 400 and 35 mg/m2 , respectively , and escalating to 1,000 and 110 mg/m2 , respectively , combined with autologous marrow transplantation .
C0025202
malignant melanoma
C0007257
bcnu